NO RESISTANCE TO TENOFOVIR ALAFENAMIDE ( TAF) IN ADULT, HBEAG- POSITIVE AND HBEAG- NEGATIVE PARTICIPANTS WITH CHRONIC HEPATITIS B INFECTION TREATED WITH TAF FOR UP TO 8 YEARS.

被引：0
|
作者：
Mateo, Roberto [1 ]
Chan, Henry Lik Yuen [2 ]
Marcellin, Patrick [3 ]
Pan, Calvin Pan [4 ]
Yazdi, Tahmineh [1 ]
Chang, Silvia [1 ]
Han, Dong [1 ]
May, Lindsey [1 ]
Marceau, Caleb [1 ]
Richards, Christopher [1 ]
Manhas, Savrina [1 ]
Ho, Pui Yan [1 ]
Li, Robert [1 ]
Xu, Simin [1 ]
Martinez, Clarissa [1 ]
Liu, Yang [1 ]
Peinovich, Nadine [1 ]
Lopez, Andrew [1 ]
Abramov, Frida [1 ]
Flaherty, John F. [1 ]
Mo, Hongmei [1 ]
Izumi, Namiki [5 ]
Buti, Maria [6 ,7 ]
Dr Shalimar [8 ]
Lim, Young-Suk [9 ]
机构：
[1] Gilead Sci Inc, Foster City, CA 94404 USA
[2] Chinese Univ Hong Kong, Hong Kong, Peoples R China
[3] Beaujon Hosp, Clichy, France
[4] NYU, Grossman Sch Med, New York, NY USA
[5] Japanese Red Cross Musashino Hosp, Dept Gastroenterol & Hepatol, Musashino, Tokyo, Japan
[6] Hosp Univ Vall Dhebron, Barcelona, Spain
[7] Inst Carlos III, Ciberehd, Barcelona, Spain
[8] All India Inst Med Sci, New Delhi, India
[9] Univ Ulsan, Coll Med, Asan Med Ctr, Seoul, South Korea
来源：
HEPATOLOGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1430-C
引用
收藏
页码：S532 / S533
页数：2
相关论文
共 50 条
  • [41] Kinetics of hepatitis B surface antigen loss in patients with HBeAg-positive chronic hepatitis B treated with tenofovir disoproxil fumarate
    Marcellin, Patrick
    Buti, Maria
    Krastev, Zahari
    de Man, Robert A.
    Zeuzem, Stefan
    Lou, Lillian
    Gaggar, Anuj
    Flaherty, John F.
    Massetto, Benedetta
    Lin, Lanjia
    Dinh, Phillip
    Subramanian, G. Mani
    McHutchison, John G.
    Flisiak, Robert
    Gurel, Selim
    Dusheiko, Geoffrey M.
    Heathcote, E. Jenny
    JOURNAL OF HEPATOLOGY, 2014, 61 (06) : 1228 - 1237
  • [42] EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE (TAF) VS TENOFOVIR DISOPROXIL FUMARATE (TDF) IN EAST ASIAN CHRONIC HEPATITIS B PATIENTS FOLLOWING 5-YEARS OF TREATMENT
    Wong, Grace Lai Hung
    Gane, Edward
    Pan, Calvin
    Lim, Young-Suk
    Fung, Scott
    Izumi, Namiki
    Ma, Mang
    Chan, Carol Yee Kwan
    Shalimar, Dr
    Buti, Maria
    GUT, 2021, 70 : A76 - A76
  • [43] Long-term follow up of HBeAg positive chronic hepatitis B treated with gamma and beta
    Kishida, Y
    Naito, M
    Katayama, K
    Kashigawa, T
    Yoshihara, H
    Kamada, T
    Akeyama, T
    Kasahara, A
    Hayashi, N
    GASTROENTEROLOGY, 1998, 114 (04) : A1276 - A1276
  • [44] HBsAg clearance in HBeAg negative infection and treated chronic hepatitis B is associated with different HBsAg kinetics
    Colombatto, P.
    Bleve, P.
    Oliveri, F.
    Cavallone, D.
    Ricco, G.
    Coco, B.
    Romagnoli, V.
    Salvati, A.
    Bonino, F.
    Brunetto, M. R.
    DIGESTIVE AND LIVER DISEASE, 2020, 52 : E27 - E28
  • [45] Is it necessary to delay antiviral therapy for 3-6 months to anticipate HBeAg seroconversion in patients with HBeAg- positive chronic hepatitis B in endemic areas of HBV genotype C? (vol 20, pg 355, 2014)
    Song, Byung-Cheol
    Cho, Yoo-Kyung
    Jwa, Hyeyoung
    Choi, Eun Kwang
    Kim, Heung Up
    Song, Hyun Joo
    Na, Soo-Young
    Boo, Sun-Jin
    Jeong, Seung Uk
    CLINICAL AND MOLECULAR HEPATOLOGY, 2015, 21 (01) : 104 - 104
  • [46] Long-term outcomes of pegylated interferon and tenofovir treatment for HBeAg-positive chronic hepatitis B infection
    Roberts, A.
    Ng, J.
    Dev, A.
    O'Neill, P.
    Sievert, W.
    Bell, S.
    Ratnam, D.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 : 81 - 81
  • [47] NO DETECTED RESISTANCE TO TENOFOVIR ALAFENAMIDE (TAF) TREATMENT IN CHILDREN AND ADOLESCENTS WITH CHRONIC HEPATITIS B (CHB): RESULTS FROM WEEK 24 PRIMARY ENDPOINT ANALYSIS
    Schwarz, Kathleen B.
    Bezerra, Jorge A.
    Liu, Yang
    Han, Dong
    Xu, Simin
    Yazdi, Tahmineh
    May, Lindsey
    Chang, Silvia
    Martin, Ross
    Mo, Hongmei
    Abramov, Frida
    Flaherty, John F.
    Rosenthal, Philip
    Chang, Mei-Hwei
    HEPATOLOGY, 2022, 76 : S255 - S256
  • [48] A phase 3 study comparing tenofovir alafenamide to tenofovir disoproxil fumarate in patients with HBeAg-negative, chronic hepatitis B: efficacy and safety results at week 96
    Brunetto, M.
    Lim, Y. S.
    Gane, E.
    Seto, W. K.
    Osipenko, M.
    Ahn, S. H.
    Janssen, H. L.
    Shukla, A.
    Chuang, W. L.
    Trinh, H.
    Celen, M. K.
    Flaherty, J. F.
    Lau, A. H.
    Gaggar, A.
    Suri, V.
    Bhardwaj, N.
    Kim, K.
    Subramanian, G. M.
    Pan, C.
    Izumi, N.
    Marcellin, P.
    Chan, H.
    Buti, M.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S25 - S26
  • [49] A PHASE 3 STUDY OF TENOFOVIR ALAFENAMIDE COMPARED WITH TENOFOVIR DISOPROXIL FUMARATE IN PATIENTS WITH HBEAG-NEGATIVE, CHRONIC HEPATITIS B: WEEK 48 EFFICACY AND SAFETY RESULTS
    Buti, M.
    Gane, E.
    Seto, W. K.
    Chan, H. L. Y.
    Chuang, W. -L.
    Stepanova, T.
    Hui, A. J.
    Lim, Y. -S.
    Mehta, R.
    Janssen, H. L. A.
    Acharya, S. K.
    Flaherty, J. F.
    Massetto, B.
    Cathcart, A.
    Dinh, P.
    Subramanian, G. M.
    McHutchison, J. G.
    Pan, C.
    Brunetto, M.
    Izumi, N.
    Marcellin, P.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S135 - S136
  • [50] PEGINTERFERON ALFA2b PLUS TDF TREATMENT OF HBEAG- NEGATIVE CHRONIC HEPATITIS B PATIENTS IN INDETERMINATE PHASE: A PILOT, OPEN- LABEL, PROSPECTIVE COHORT STUDY
    Liu, Min
    Zhang, Yuting
    Zuo, Lili
    Xiao, An
    Yue, Wei
    Bu, Bing
    Wang, Yilan
    Chen, Jiayi
    Zhu, Ling
    Geng, Jiawei
    Xia, Xueshan
    HEPATOLOGY, 2023, 78 : S538 - S539
12345